OLR1 and cancer: One study accentuated the difference between the PMN-MDSCs of patients with cancer and healthy individuals by showing that tumor-associated PMN-MDSCs expressed lectin-type oxidized LDL receptor 1 (LOX-1), whereas their normal equivalents did not (91).